Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP209107.RAqjKYhPj5lIA7pnq4Di1DCQK4e_WLvKp4tVu2OXVemFo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP209107.RAqjKYhPj5lIA7pnq4Di1DCQK4e_WLvKp4tVu2OXVemFo130_assertion type Assertion NP209107.RAqjKYhPj5lIA7pnq4Di1DCQK4e_WLvKp4tVu2OXVemFo130_head.
- NP209107.RAqjKYhPj5lIA7pnq4Di1DCQK4e_WLvKp4tVu2OXVemFo130_assertion description "[An unacceptable recurrence/persistence rate (80%) associated with increasingly difficult re-operations and risk of parathyroid carcinoma in the setting of germline mutations of HRPT2 gene with familial hyperparathyroidism suggest that a more aggressive operative approach should be undertaken in these patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP209107.RAqjKYhPj5lIA7pnq4Di1DCQK4e_WLvKp4tVu2OXVemFo130_provenance.
- NP209107.RAqjKYhPj5lIA7pnq4Di1DCQK4e_WLvKp4tVu2OXVemFo130_assertion evidence source_evidence_literature NP209107.RAqjKYhPj5lIA7pnq4Di1DCQK4e_WLvKp4tVu2OXVemFo130_provenance.
- NP209107.RAqjKYhPj5lIA7pnq4Di1DCQK4e_WLvKp4tVu2OXVemFo130_assertion SIO_000772 18436011 NP209107.RAqjKYhPj5lIA7pnq4Di1DCQK4e_WLvKp4tVu2OXVemFo130_provenance.
- NP209107.RAqjKYhPj5lIA7pnq4Di1DCQK4e_WLvKp4tVu2OXVemFo130_assertion wasDerivedFrom befree-20140225 NP209107.RAqjKYhPj5lIA7pnq4Di1DCQK4e_WLvKp4tVu2OXVemFo130_provenance.
- NP209107.RAqjKYhPj5lIA7pnq4Di1DCQK4e_WLvKp4tVu2OXVemFo130_assertion wasGeneratedBy ECO_0000203 NP209107.RAqjKYhPj5lIA7pnq4Di1DCQK4e_WLvKp4tVu2OXVemFo130_provenance.